A Laboratory Branch Task Force of the National Communicable Disease Center has proposed a standardized complement fixation procedure (LBCF) and an adaptation of this to microtitration techniques (MT) as uniform methods for performing complement fixation (CF) tests. A common procedure should make CF results from one laboratory more comparable to another. In addition, it would be preferable if the common procedure reproduced the titer levels of a testing procedure which is to be replaced, particularly when valid clinical interpretations have been derived from the latter. Replicated sets of sera were tested by the LBCF, MT, and the standard Smith CF procedure for coccidioidomycosis. Results with all three procedures were highly reproducible within an acceptable one-tube variation of a twofold dilution series, but the frequency of one-tube variations was greater with the MT method than with the other two. There was no statistical difference in the titers obtained with the Smith and LBCF procedures, but there was a significant difference when the MT results were compared to those with the Smith method. The LBCF method should be acceptable as a standardized and uniform CF procedure for coccidioidomycosis, subject to comparative testing between different laboratories.
The immunological tests for coccidioidomycosis, as developed and evaluated for clinical interpretations by Smith and his colleagues (9, 11) , have been among the most useful and practical laboratory procedures employed for an infectious disease. The quantitative complement fixation (CF) test has been particularly valuable. Under appropriate circumstances, it can serve as a diagnostic aid, as a measure of the severity and extent of disease, or as an objective guide for clinical management of the patient. Analysis of the results obtained in Smith's laboratory indicated that CF titers generally paralleled the extent and severity of the disease, except for cases with meningitis, and that the "critical titer" was 1:16; i.e., 95% of specimens from patients with uncomplicated pulmonary disease yielded titers of 1:16 or lower, whereas 83% of specimens from patients with extensive, nonmeningeal, extrapulmonary disease exceeded this critical titer. Increasing confidence in the reliability of these interpretations has been founded on the continued accuracy and reproducibility of the CF titers when using the procedure of Smith. Unfortunately, however, comparative tests on the same specimens and with the same batch of antigen (coccidioidin) by four laboratories using five different procedures for CF revealed that the critical titer varied according to the laboratory and the procedure employed, even though the correlation between high titers and severity of disease was retained (10) . As a consequence, most physicians have been compelled to send specimens only to those few laboratories which use the procedure of Smith for CF tests and to accept a delay in receiving the results.
Since the titers of CF tests for coccidioidomycosis are so valuable, it is advantageous for the physician to know the results of such tests as early as possible. Recently, coccidioidin antigen has become available, and an increasing number of laboratories are performing CF tests for coccidioidomycosis. Although it is imperative that the validity of the "critical titer" interpretation should be preserved, it is appropriate also that consideration be given to a uniform testing procedure. Kaufman (7) and others (12) have pointed out that a rigidly controlled procedure could yield reproducible results among different laboratories. The Laboratory Branch Complement Fixation (LBCF) method had been developed and evaluated for this purpose by a Task Force of the National Communicable Disease Center, pointing out that, "A standardized complement fixation (CF) procedure, useful with all diagnostic CF antigens, has long been needed.
Until such a procedure is established, CF results from one laboratory cannot be compared with those of another" (12) .
For the past eleven years we have used the procedure of Smith for CF tests for coccidioidomycosis, but it appeared to us that the time had come to consider replacing this procedure with one which would have more general acceptance. In this report, we compare the results obtained with three CF procedures-the LBCF method, the adaptation of the LBCF method to the microtiter (MT) technique, and the Smith procedure as used in our laboratory. We hoped one of these proposed substitute methods would not change the critical titer, and our results indicate that this change does not occur with the full volume LBCF procedure.
MAITERIALS AND METHODS
The procedure used for the full volume LBCF and the adaptation of the LBCF to the MT technique were those recommended by the Laboratory Task Force (12) . The titers obtained with these two procedures were compared to results with the second method of Smith in which the original 2-hr incubation at 37 C for binding of complement is replaced by overnight incubation at 5 C. This has raised the "critical titer" from 1:16 to 1:32 in Smith's laboratory (11) and in ours, based on results of testing more than 16,000 specimens. The overnight incubation procedure was adopted by us originally on the recommendation of Smith as being more sensitive than incubation at 37 C for 2 hr and less likely to yield false-negative results with sera of low titer.
The solution of antigen (coccidioidin) used in all tests was prepared as described earlier from a pool of filtrates obtained from shake cultures of 24 strains of Coccidioides immitis grown in a dialyzed yeast extract-glucose broth (3, 5) . The pooled filtrate was concentrated to one-tenth of the original volume by ultrafiltration behind a 4% collodion membrane and then washed by the same procedure with phosphate-buffered saline (pH 7.2) containing thimerosal at a final concentration of 1:10,000. The optimal dilution of this coccidioidin was determined for each CF procedure by preliminary titration of dilutions of the antigen against a reference serum. This was repeated several times with a narrowing range of antigen dilutions, and, with this lot of coccidioidin, the final optimal titer of antigen was the same for all three procedures; i.e., a 1:300 dilution of stock antigen. The optimal dilution of the coccidioidin was confirmed by testing a battery of 10 specimens with known titers.
Serum specimens were obtained from the clinical laboratory of this hospital. These had been screened routinely for reactions to coccidioidin in both agar gel immunodiffusion and latex particle agglutination tests (6) , and positive specimens had been confirmed with the quantitative CF test of Smith. To permit valid statistical comparisons of the three CF procedures, the following "blind" protocol was adopted. Twenty specimens in each of two sets were coded according to a table of random numbers by a person other than the one performing the test. After all three CF procedures were completed and the results were recorded, the same 20 specimens in each set were coded with new numbers and the tests were repeated. This protocol permitted an evaluation of reproducibility for each method as well as a comparison among the three procedures. In addition, a series of consecutive specimens which were positive in at least one of the screening tests for coccidioidomycosis were selected for routine testing of each specimen by all three CF procedures.
The results were evaluated for statistical significance by two methods. The chi square (x2) value was determined with the NcNemar test for the significance of changes among two sets of responses for the same specimens (8) . A difference of proportions test (w'), as a measure of association between any two procedures when compared to a standard procedure, was calculated by a modification of the method of Chase (1, 2) . Since the theory and derivation of this modification will be published separately ( 
RESULTS
Among the specimens selected for use in the "blind" protocol, four or five known negative sera were included in each set to avoid a potential bias in the readings which might have been introduced if the reader expected all specimens to yield positive results. The CF titers of these positive specimens ranged from 1:2 to 1:128 as determined earlier by the Smith procedure. Reproducibility for each CF procedure was measured by comparing the results obtained with the replicated sets of coded specimens. Each procedure was highly reproducible within the generally accepted limit of a one-tube difference in a twofold dilution series (Table 1, aAnticomplementary specimens not included. These results demonstrated that either the LBCF or MT tests could be substituted for the Smith procedure when a one-tube error in the titer was considered acceptable. There was some evidence, however, that the LBCF method was better than the MT method for reproducing the exact titers obtained with the Smith test. To test this under routine laboratory conditions, the three CF tests were performed on a consecutive series of specimens which were positive by screening tests for coccidioidomycosis (6) . The results (Table 4-6) confirmed the above observation that the frequency of deviations from the exact titer obtained by the Smith method was greater for the MT test than for the LBCF procedure. The chi square and the difference of proportions tests were used to determine whether there was a difference between the LBCF and MT (Table 6 ) indicated that the null hypothesis (i.e., there was no difference between the LBCF and MT tests as substitutes for the Smith test) should be rejected with a high level of confidence, and that the LBCF method was superior to the MT as a substitute for the standard Smith procedure. Another approach to interpretation of these results is to ask what is the probability of a difference in titer occurring with the LBCF and MT procedures, respectively, when compared to titers obtained with the Smith procedure on the same specimen. At a 99% confidence interval, the probability of obtaining titers within one tube of that with the Smith procedure is 0.977 + 0.029 for the LBCF procedure and 0.925 4 0.052 for 
